TMune Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 2

TMune Therapeutics General Information

Description

Developer of T-cell therapies designed to treat cancer. The company's therapies help in the treatment of cancer, lymphoma, HIV, and other infectious diseases, enabling patients to get cured and lead healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Corporate Office
  • 2119 Delancey Street
  • Philadelphia, PA 19103
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TMune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO 03-Jan-2012 $1.5M 0000 00.00 Completed Startup
2. Grant 01-Jan-2009 0000 Completed Startup
1. Early Stage VC (Series A) 29-Feb-2008 $13M $13M 000.00 Completed Startup
To view TMune Therapeutics’s complete valuation and funding history, request access »

TMune Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
To view TMune Therapeutics’s complete cap table history, request access »

TMune Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Louis Berneman Co-Founder, Principal, Chief Executive Officer, Director and Co-President
Douglas Lind MD President & Board Member
Carl June MD Scientific Co-Founder & Scientific Advisory Board Member
To view TMune Therapeutics’s complete executive team members history, request access »

TMune Therapeutics Board Members (4)

Name Representing Role Since
Carl June MD Self Scientific Co-Founder & Scientific Advisory Board Member 000 0000
David Wetherell Biomark Capital Board Member 000 0000
Douglas Lind MD Self President & Board Member 000 0000
Joydeep Goswami Ph.D Self Board Member 000 0000
To view TMune Therapeutics’s complete board members history, request access »

TMune Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biomark Capital PE/Buyout Majority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view TMune Therapeutics’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »